Adjustable-Flow Glaucoma Shunts for Noninvasive Resistance Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing glaucoma shunts provide constant resistance to fluid flow, requiring invasive and time-consuming adjustments to manage changing outflow resistance during the healing process, which can lead to complications such as hypotony.
Innovation Solution
Development of adjustable flow glaucoma shunts with mechanisms like inflow control assemblies and actuators that can modulate fluid resistance and opening pressure in response to intraocular pressure changes, using non-invasive energy to adjust aperture sizes and flow paths.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If traditional constant resistance shunts are used, then the device structure is simple, but the outflow resistance cannot be adjusted to match changing physiological conditions during healing
Solution Approach 1:
The shunt incorporates an adjustable flow control mechanism that transitions from a static constant resistance design to a dynamic adjustable resistance system. The flow control assembly includes movable components that can change aperture size and flow characteristics in response to varying intraocular pressure conditions during the healing process, enabling the device to adapt its resistance characteristics over time
Solution Approach 2:
The invention changes the resistance parameter of the shunt from fixed to variable. By incorporating adjustable apertures and flow control elements, the system can modify its hydraulic resistance to match the changing outflow requirements of the eye during healing, allowing optimization of aqueous humor drainage at different stages of recovery
2Ease of operation
If invasive procedures are performed to adjust shunt resistance, then the outflow resistance can be modified, but the adjustment process is time-consuming and carries surgical risks
Solution Approach 1:
The shunt incorporates self-adjustment capabilities through its flow control assembly, which can modify its own resistance characteristics without requiring external surgical intervention. The device includes mechanisms that respond automatically to pressure differential changes, allowing the shunt to self-regulate its flow resistance in response to varying physiological conditions
Solution Approach 2:
The invention replaces invasive mechanical surgical adjustment procedures with a non-invasive or minimally invasive adjustment mechanism. The flow control assembly uses internal mechanical or electromechanical means to adjust resistance, eliminating the need for repeated surgical openings and manual repositioning of the shunt
3Reliability
If the shunt provides constant resistance, then the device is simple to manufacture, but it cannot prevent hypotony when outflow resistance becomes too low during healing
Solution Approach 1:
The shunt incorporates a feedback mechanism through its flow control assembly that responds to changes in intraocular pressure and outflow resistance. The device monitors flow conditions and automatically adjusts its resistance characteristics to maintain optimal pressure levels, preventing both high pressure (glaucoma) and low pressure (hypotony) conditions during the healing process
Data Source
AI summary
Systems and devices for facilitating the flow of fluid between a first body region and a second body region are disclosed herein. The devices generally include a drainage and/or shunting element having a lumen extending therethrough for draining or otherwise shunting fluid between the first and second body regions. Further, devices configured in accordance with the present technology may be selectively adjustable to control the amount of fluid flowing between the first and second body regions. In some embodiments, for example, the devices comprise an actuation assembly that drives movement of a flow control element to modulate flow resistance through the lumen, thereby increasing or decreasing the relative drainage rate of fluid between the first body region and the second body region.